Dr Brian S Parsley, MD | |
5420 West Loop S, Suite 5420, Bellaire, TX 77401-2107 | |
(713) 333-9333 | |
(713) 333-9343 |
Full Name | Dr Brian S Parsley |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 41 Years |
Location | 5420 West Loop S, Bellaire, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366522781 | NPI | - | NPPES |
133071408 | Medicaid | TX | |
133071409 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | G6751 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Encompass Home Health Of Houston | Houston, TX | Home health agency |
Encompass Home Health Of Houston | Houston, TX | Home health agency |
Encompass Home Health Of Houston | Richmond, TX | Home health agency |
Houston Methodist Hospital | Houston, TX | Hospital |
Houston Methodist Sugarland Hospital | Sugar land, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Tmh Physician Associates Pllc | 4486711744 | 1557 |
News Archive
Bladder cancer often becomes aggressive and spreads in patients despite treatment, but now researchers at the Kimmel Cancer Center at Jefferson have identified a protein they believe is involved in pushing tumors to become invasive - and deadly.
Scientists at the University of Waterloo have developed a new tool to protect women from HIV infection.
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday named former HHS Secretary Michael Leavitt and former President of Botswana Festus Mogae to co-chair "an external review of its financial systems, amid heightened scrutiny from donors over misuse of some grants and a potential funding reduction from the U.S.," the Wall Street Journal reports.
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced an independent data monitoring committee (IDMC) has recommended the continuation of the company's pivotal phase 3 ADAPT clinical trial of AGS-003 for the treatment of metastatic renal cell carcinoma (mRCC) following the first of three planned interim data analyses.
› Verified 3 days ago
Entity Name | Ut Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033157821 PECOS PAC ID: 8426960360 Enrollment ID: O20031107000268 |
News Archive
Bladder cancer often becomes aggressive and spreads in patients despite treatment, but now researchers at the Kimmel Cancer Center at Jefferson have identified a protein they believe is involved in pushing tumors to become invasive - and deadly.
Scientists at the University of Waterloo have developed a new tool to protect women from HIV infection.
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday named former HHS Secretary Michael Leavitt and former President of Botswana Festus Mogae to co-chair "an external review of its financial systems, amid heightened scrutiny from donors over misuse of some grants and a potential funding reduction from the U.S.," the Wall Street Journal reports.
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced an independent data monitoring committee (IDMC) has recommended the continuation of the company's pivotal phase 3 ADAPT clinical trial of AGS-003 for the treatment of metastatic renal cell carcinoma (mRCC) following the first of three planned interim data analyses.
› Verified 3 days ago
Entity Name | Tmh Physician Associates Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275779225 PECOS PAC ID: 4486711744 Enrollment ID: O20090401000100 |
News Archive
Bladder cancer often becomes aggressive and spreads in patients despite treatment, but now researchers at the Kimmel Cancer Center at Jefferson have identified a protein they believe is involved in pushing tumors to become invasive - and deadly.
Scientists at the University of Waterloo have developed a new tool to protect women from HIV infection.
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday named former HHS Secretary Michael Leavitt and former President of Botswana Festus Mogae to co-chair "an external review of its financial systems, amid heightened scrutiny from donors over misuse of some grants and a potential funding reduction from the U.S.," the Wall Street Journal reports.
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced an independent data monitoring committee (IDMC) has recommended the continuation of the company's pivotal phase 3 ADAPT clinical trial of AGS-003 for the treatment of metastatic renal cell carcinoma (mRCC) following the first of three planned interim data analyses.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Brian S Parsley, MD 5420 West Loop S, Suite 5420, Bellaire, TX 77401-2107 Ph: (713) 333-9333 | Dr Brian S Parsley, MD 5420 West Loop S, Suite 5420, Bellaire, TX 77401-2107 Ph: (713) 333-9333 |
News Archive
Bladder cancer often becomes aggressive and spreads in patients despite treatment, but now researchers at the Kimmel Cancer Center at Jefferson have identified a protein they believe is involved in pushing tumors to become invasive - and deadly.
Scientists at the University of Waterloo have developed a new tool to protect women from HIV infection.
The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday named former HHS Secretary Michael Leavitt and former President of Botswana Festus Mogae to co-chair "an external review of its financial systems, amid heightened scrutiny from donors over misuse of some grants and a potential funding reduction from the U.S.," the Wall Street Journal reports.
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer based on the Arcelis technology platform, today announced an independent data monitoring committee (IDMC) has recommended the continuation of the company's pivotal phase 3 ADAPT clinical trial of AGS-003 for the treatment of metastatic renal cell carcinoma (mRCC) following the first of three planned interim data analyses.
› Verified 3 days ago
Ernest U Conrad Iii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5420 West Loop S Ste 2400, Bellaire, TX 77401 Phone: 713-486-3550 | |
William Hicks Hadnott Iii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5420 West Loop S Ste 2400, Bellaire, TX 77401 Phone: 713-486-3550 Fax: 713-383-1473 | |
Dr. David Long-i Lin, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5420 West Loop S, Suite 2300, Bellaire, TX 77401 Phone: 716-509-6900 Fax: 713-650-4900 | |
Navin Subramanian, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5420 West Loop S, Suite 2300, Bellaire, TX 77401 Phone: 713-650-6900 Fax: 713-650-6500 | |
David Booty Doherty Jr., Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5420 West Loop S Ste 2400, Bellaire, TX 77401 Phone: 713-486-3550 Fax: 713-314-2990 | |
Dr. Henry J Blum, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5420 West Loop South, Suite 2400, Bellaire, TX 77401 Phone: 713-314-4600 Fax: 713-314-2990 |